Article
Reduction of clonal hematopoiesis mutation burden in coronary patients treated with low-dose colchicine
2024-10-18
Abstract excerpt
<h4>ABSTRACT</h4> Clonal hematopoiesis involves mutations in hematopoietic stem/progenitor cells, which increase the risk of cardiovascular disease, particularly under pro-inflammatory conditions. This study assessed the impact of the anti-inflammatory medication colchicine on clonal hematopoiesis in patients with recent myocardial infarction from the COLCOT trial. Participants were randomly assigned to low-dose...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 50de41b8-8e4b-5922-a756-5c5bed6b8451
- DOI
- 10.1101/2024.10.17.24315679
